Publications

2003

Jang B-, Muñoz-Najar U, Paik J-, Claffey K, Yoshida M, Hla T. Leptomycin B, an inhibitor of the nuclear export receptor CRM1, inhibits COX-2 expression. J Biol Chem. 2003;278(5):2773-6.
Leibowitz SB, Garber JE, Fox EA, Loda M, Kaufman DS, Kantoff PW, et al. Male patients with diagnoses of both breast cancer and prostate cancer. Breast J. 2003;9(3):208-12.
Barbareschi M, Togni R, Aldovini D, Peterlini G, Dal Santo M, Sagramoso C, et al. [Tissue microarrays in oncology]. Pathologica. 2003;95(5):265-6.
Hinoi T, Loda M, Fearon ER. Silencing of CDX2 expression in colon cancer via a dominant repression pathway. J Biol Chem. 2003;278(45):44608-16.
Cong F, Zhang J, Pao W, Zhou P, Varmus H. A protein knockdown strategy to study the function of beta-catenin in tumorigenesis. BMC Mol Biol. 2003;4:10.
Li Y, Yu W-, Ren J, Chen W, Huang L, Kharbanda S, et al. Heregulin targets gamma-catenin to the nucleolus by a mechanism dependent on the DF3/MUC1 oncoprotein. Mol Cancer Res. 2003;1(10):765-75.
Kukoski R, Blonigen B, Macri E, Renshaw AA, Hoffman M, Loda M, et al. p27 and cyclin E/D2 associations in testicular germ cell tumors: implications for tumorigenesis. Appl Immunohistochem Mol Morphol. 2003;11(2):138-43.
Moscat J, Diaz-Meco MT. Par-4 keeps the atypical PKCs at bay. Cell Cycle. 2003;2(2):71-2.
Rickman DS, Herbert CJ, Aggerbeck LP. Optimizing spotting solutions for increased reproducibility of cDNA microarrays. Nucleic Acids Res. 2003;31(18):e109.

Pathology & Laboratory Medicine 1300 York Avenue New York, NY 10065 Phone: (212) 746-6464
Surgical Pathology: (212) 746-2700